• Aucun résultat trouvé

WHO response

N/A
N/A
Protected

Academic year: 2022

Partager "WHO response"

Copied!
1
0
0

Texte intégral

(1)

Eliminating mother-to-child transmission of HIV, hepatitis B and syphilis

Key facts

Fact sheet: August 2017

SMALL PHOTO

facebook.com/WHOWPRO @WHOWPRO youtube.com/WHOWPRO www.wpro.who.int

Every year in the WHO Western Pacific Region,

180 000

babies are infected with hepatitis B,

13 000

with syphilis and

1400

with HIV.

These infections can be largely prevented by screening and treating mothers during pregnancy and vaccinating newborns shortly after birth.

Poor coordination and inefficiencies among

programmes in health systems often force women and their babies to seek these services separately. This is a barrier to quality care.

The shared maternal, newborn and child health platform can coordinate and integrate interventions to achieve efficiencies and cost-effectively prevent these infections to achieve elimination.

Every child should be given the best chance to start life healthy and free from preventable diseases. HIV, hepatitis B and syphilis can be transmitted from mother to child during pregnancy, birth and breastfeeding. But these infections can be effectively prevented by immunization, and screening and treatment of pregnant women.

In this Region, most mothers and children receive health services during pregnancy, delivery and in the months after birth. However, when services for HIV, hepatitis B and syphilis are planned and delivered through separate, uncoordinated, vertical programmes in the health system, this can result in redundancies, missed opportunities, and an inefficient use of resources. It can also make it harder for women and babies to get these important services.

The Regional Framework for the Triple Elimination of Mother-to-child Transmission of HIV, Hepatitis B and Syphilis in Asia and the Pacific 2018–2030 will help countries adopt a coordinated approach to delivering these interventions using the shared Maternal, Newborn and Child Health platform.

Examples of better coordination include simultaneous screening for HIV, hepatitis B and syphilis during a pregnant woman’s first prenatal care visit, prompt referral of women who are found to be positive to relevant specialists for treatment, and providing feedback to midwives administering a dose of hepatitis B vaccine at birth.

Economic evaluations have found integrated and coordinated approaches to eliminating mother-to-child transmission to be highly cost-effective. This is increasingly important in the face of declining external funding and the need to rely on sustainable domestic financing.

WHO convened consultations with Member States and experts to develop the Regional Framework. WHO is working with partners to support countries in the Western Pacific Region to strengthen and coordinate approaches through the Maternal, Newborn and Child Health platform.

Implementation of the Regional Framework will contribute to achieving and sustaining elimination of mother-to-child transmission of HIV, hepatitis B and syphilis.

WHO response

WPR/2017/RDO/006

© World Health Organization 2017

Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO license.

Références

Documents relatifs

Some characteristics that are linked to mother-to-child transmission (MTCT) of HTLV-1, such as the role of proviral load, antibody titer of the infected mother, and duration

The results of the analysis suggest that if the viral hepatitis response reaches five prevention and treatment service coverage targets (see Table 1), hepatitis B and C could

The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions; 2012 d WHO/UNICEF joint reporting process; 2019 e

☆ Valid method was used to ascertain adherence to the antiviral therapy (decrease in viral load levels subsequent to the treatment). ☆ Always the

The costs (Table 2) in this analysis include the costs of the diagnostic tests (HBsAg test, HBeAg test and HBV viral load test), the cost of antiviral therapy for all those

1) Conduct desk reviews of the information submitted by the countries for verification of the regional hepatitis B control goal as per protocol established in the Global health

This Regional Strategy to remove the barriers to universal access and harm reduction to halt the spread of HIV and hepatitis C among people who inject drugs in Asia and the Pacific

Figure1a: Conceptual model for socio-economic, clinical and biological risk factors for mother – to – child transmission of HIV-1---18 Figure1b: Trends in selected